DANA AND ALBERT "CUBBY" BROCCOLI PROFESSORSHIP IN ONCOLOGY
Established in 2001 by Dana Broccoli and the Broccoli Foundation

DANA BROCCOLI was a philanthropist, novelist, producer, actress, and creative muse. She collaborated with her husband, ALBERT ROMOLO "CUBBY" BROCCOLI, on the production of more than 15 films. The couple launched the James Bond series, the most successful film franchise in Hollywood history. In recognition of that achievement, Mr. Broccoli received the Irving G. Thalberg Award from the Academy of Motion Picture Arts and Sciences, the Order of the British Empire from Queen Elizabeth II, and the title Commandeur des Arts et des Lettres from the French government. With his death, Mrs. Broccoli became the custodian of the James Bond franchise and, as such, she was lauded for her contributions by the Ian Fleming Foundation. Dana Broccoli died in 2004.

 

With her children, Barbara Broccoli and Michael Wilson, Mrs. Broccoli founded the DANA AND ALBERT R. BROCCOLI CHARITABLE FOUNDATION to support the arts, children's services, medicine, and higher education. At Johns Hopkins, the foundation has established the Dana and Albert "Cubby" Broccoli Center for Aortic Diseases and supported the Walter J. Stark Distinguished Professorship in Ophthalmology. In addition, the Broccoli family has donated the proceeds from the East Coast premieres of three James Bond films to Hopkins and the Broccoli Center for Aortic Diseases. In 2001, the foundation established the Dana and Albert "Cubby" Broccoli Professorship in Oncology to advance discovery in breast cancer and vaccine therapies at the Sidney Kimmel Comprehensive Cancer Center.

 

ELIZABETH M. JAFFEE, the inaugural Dana and Albert "Cubby" Broccoli Professor in Oncology and director of the Cell and Gene Therapy Laboratory, is developing novel, potent vaccines for the treatment and prevention of cancer. An internationally recognized leader in cancer research, Dr. Jaffee came to Hopkins in 1989 as a fellow and joined the faculty in 1992. Her laboratory focuses predominantly on two diseases: breast cancer and pancreatic cancer. She led the effort to develop clinical vaccines, essentially creating the blueprint for a major cancer gene therapy approach that has been used in over 30 institutions worldwide. The vaccine approach, using genetically altered tumor cells to activate the immune system, redefines the concept of immunity and harnesses the immune system as a major player in the war against pancreatic cancer. Widely published, she holds numerous patents, and serves on several national committees.